A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 143
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : F. nucleatum
Long Form : Fusobacterium nucleatum
No. Year Title Co-occurring Abbreviation
2023 Colonization of Fusobacterium nucleatum is an independent predictor of poor prognosis in gastric cancer patients with venous thromboembolism: a retrospective cohort study. GC, HR, PLR, VTE
2023 Virulence Factors of the Periodontal Pathogens: Tools to Evade the Host Immune Response and Promote Carcinogenesis. A. actinomycetemcomitans, P. gingivalis
2022 A case report of severe Fusobacterium nucleatum sepsis secondary to nephrectomy. ---
2022 A positive feed-forward loop between Fusobacterium nucleatum and ethanol metabolism reprogramming drives laryngeal cancer progression and metastasis. ADH1B, LSCC, TGFBR2
2022 An injectable multifunctional thermo-sensitive chitosan-based hydrogel for periodontitis therapy. P. gingivalis, ROS, S. gordonii
2022 Antibiofilm activity of ultra-small gold nanoclusters against Fusobacterium nucleatum in dental plaque biofilms. ---
2022 Antimicrobial behavior of titanium coating with chlorhexidine-doped thin film exposed to a biofilm supplemented with nicotine. ---
2022 Bacterial Involvement in Progression and Metastasis of Adenocarcinoma of the Stomach. H. pylori, M. hyorhinis
2022 Clinical Significance of Fusobacterium nucleatum and Microsatellite Instability in Evaluating Colorectal Cancer Prognosis. CRC, DFS, FFPE, MSI, ROC
10  2022 Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis. 5-FU, CRC, DOR, NLR, PLR
11  2022 Effect of gut microbiota in the colorectal cancer and potential target therapy. CRC, ETBF, S. bovis
12  2022 Evaluating the predictive performance of gut microbiota for the early-stage colorectal cancer. AUCs, CRC, CrI, LCMs, S. bovis
13  2022 Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism. DAI, DSS, IECs, TNF-alpha, UC
14  2022 Fusobacterium nucleatum and its associated systemic diseases: epidemiologic studies and possible mechanisms. ---
15  2022 Fusobacterium nucleatum and Malignant Tumors of the Digestive Tract: A Mechanistic Overview. ---
16  2022 Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck. dMMR, HNSCC, MMR, MSI
17  2022 Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer. CRC
18  2022 Fusobacterium nucleatum load in MSI colorectal cancer subtypes. CRC, MSI, MSS
19  2022 Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model. AOM/DSS, CRC
20  2022 Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-kappaB/ICAM1 axis. CRC
21  2022 Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota. CRC, NK, Th17
22  2022 Fusobacterium nucleatum promotes the development of acute liver failure by inhibiting the NAD+ salvage metabolic pathway. ALF
23  2022 Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis. CRC, FOXD3, KIF26B, PDX
24  2022 Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer. CRC
25  2022 Fusobacterium nucleatum Subspecies Differ in Biofilm Forming Ability in vitro. CV
26  2022 Fusobacterium nucleatum triggers proinflammatory cell death via Z-DNA binding protein 1 in apical periodontitis. AP, F. nucleatum-EVs, GSDME, PANoptosis, ZBP1
27  2022 Fusobacterium nucleatum: The Opportunistic Pathogen of Periodontal and Peri-Implant Diseases. ---
28  2022 Graphene Coated Ti-6Al-4V Exhibits Antibacterial and Antifungal Properties Against Oral Pathogens. C. albicans, P. gingivalis, ROS, SEM
29  2022 Interactions Between Streptococcus gordonii and Fusobacterium nucleatum Altered Bacterial Transcriptional Profiling and Attenuated the Immune Responses of Macrophages. S. gordonii
30  2022 Investigation of Fusobacterium Nucleatum in saliva and colorectal mucosa: a pilot study. CRN
31  2022 Involvement of Fusobacterium nucleatum in malignancies except for colorectal cancer: A literature review. CRC, EMT
32  2022 Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis. CRC, EMT, lncRNA, YBX1
33  2022 Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences. AA, CA, CRC
34  2022 Neutrophil Transcriptional Deregulation by the Periodontal Pathogen Fusobacterium nucleatum in Gastric Cancer: A Bioinformatic Study. CCGD, DEGs, GO, PPI
35  2022 Outer Membrane Vesicles From Fusobacterium nucleatum Switch M0-Like Macrophages Toward the M1 Phenotype to Destroy Periodontal Tissues in Mice. BMDMs, LDH, MGFs, OMVs, TRAP
36  2022 Pathogenic Mechanisms of Fusobacterium nucleatum on Oral Epithelial Cells. PAMPs, PRRs
37  2022 Safe-by-Design Antibacterial Peroxide-Substituted Biomimetic Apatites: Proof of Concept in Tropical Dentistry. A. actinomycetemcomitans, P. gingivalis
38  2022 Soybean peptide inhibits the biofilm of periodontopathic bacteria via bactericidal activity. MBC, MIC, P. gingivalis, PI, S. mitis
39  2022 The stimulatory effect of fusobacteria on dendritic cells under aerobic or anaerobic conditions. DCs, E. coli, F. varium, L. bulgaricus, MFI
40  2022 Transcriptome analysis of Fusobacterium nucleatum reveals differential gene expression patterns in the biofilm versus planktonic cells. ---
41  2022 Vanillin Derivatives Reverse Fusobacterium nucleatum-Induced Proliferation and Migration of Colorectal Cancer Through E-Cadherin/beta-Catenin Pathway. CRC
42  2021 ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of Fusobacterium nucleatum in Colorectal Cancer. ANGPTL4
43  2021 Anti-Early Stage of Bacterial Recolonization Effect of Curcuma longa Extract as Photodynamic Adjunctive Treatment. LEDs, P. intermedia, PCR, PDT, SRP
44  2021 Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study. CRC
45  2021 Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment. CI, MSI, TAM
46  2021 Clinical Significance of Fusobacterium nucleatum Infection and Regulatory T Cell Enrichment in Esophageal Squamous Cell Carcinoma. ESCC
47  2021 Detection of Fusobacterium nucleatum subspecies in the saliva of pre-colorectal cancer patients, using tandem mass spectrometry. CRA, CRC
48  2021 Effect of Theaflavin on Oral Bacteria in Japanese Subjects: A Randomized, Placebo-Controlled, Double-Blind Study. P. gingivalis, TFs
49  2021 Fecal Fusobacterium nucleatum harbored virulence gene fadA are associated with ulcerative colitis and clinical outcomes. CRC, CRP, ESR, HC, IBS-D, PCR, UC, WBC
50  2021 Fusobacterium nucleatum - Friend or foe? ---
51  2021 Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality. CRC, TME
52  2021 Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients. H. pylori
53  2021 Fusobacterium nucleatum Promotes Cisplatin-Resistance and Migration of Oral Squamous Carcinoma Cells by Up-Regulating Wnt5a-Mediated NFATc3 Expression. NFATc3
54  2021 Gene expression profiles of mitochondria-endoplasmic reticulum tethering in human gingival fibroblasts in response to periodontal pathogens. GRP75, IER3, Mfn1, P. gingivalis, PINK1, SIGMAR1, TNF-alpha
55  2021 Impact of Fusobacterium nucleatum in the gastrointestinal tract on natural killer cells. CRC, IHC, NK, PBS
56  2021 Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment. A. muciniphila, H. hepaticus, L. reuteri, NK cells, TME
57  2021 Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with Fusobacterium nucleatum and Its Subspecies animalis. CI
58  2021 One gut microbiota, Fusobacterium nucleatum aggravates Neonatal necrotizing enterocolitis by induction of IRF5 expression through lncRNA ENO1-IT1/miR-22-3p axis. NEC
59  2021 Porphyromonas gingivalis outer membrane vesicles inhibit the invasion of Fusobacterium nucleatum into oral epithelial cells by downregulating FadA and FomA. OMVs, P. gingivalis
60  2021 Prediagnostic Antibody Responses to Fusobacterium nucleatum Proteins Are Not Associated with Risk of Colorectal Cancer in a Large U.S. Consortium. ---
61  2021 Receptor-interacting protein kinase 2 contributes to host innate immune responses against Fusobacterium nucleatum in macrophages and decidual stromal cells. APOs, BMDMs, hDSCs, NO, NOD, RIPK2, WT
62  2021 The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer. CAP, CRC, ROC
63  2020 Brain abscess in a patient with psoriatic arthritis treated with adalimumab: A case report. MRI, P. micra, S. sanguinis
64  2020 Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy. ELISA, G. adiacens, HGD, IPMNs, S. gordonii
65  2020 Detection of Fusobaterium nucleatum in feces and colorectal mucosa as a risk factor for colorectal cancer: a systematic review and meta-analysis. CRC, OR, PROSPERO
66  2020 Efficacy of antimicrobial photodynamic and photobiomodulation therapy against Treponema denticola, fusobacterium nucleatum and human beta defensin-2 levels in patients with gingivitis undergoing fixed orthodontic treatment: A clinic-laboratory study. aPDT, FMPS, GCF, hBD, PBM, PD, T. denticola, US
67  2020 First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening. E. coli, F. prausnitzii, FIT
68  2020 Fusobacterium nucleatum Activates Endoplasmic Reticulum Stress to Promote Crohn's Disease Development via the Upregulation of CARD3 Expression. CARD3, CD, ERS
69  2020 Fusobacterium nucleatum Causes Microbial Dysbiosis and Exacerbates Visceral Hypersensitivity in a Colonization-Independent Manner. IBS, IBS-D, MS
70  2020 Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma. ESCC
71  2020 Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation. DSS, IBD, IL
72  2020 Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients. CRC, GC
73  2020 Fusobacterium nucleatum Promotes Metastasis in Colorectal Cancer by Activating Autophagy Signaling via the Upregulation of CARD3 Expression. AOM, CQ, CRC, DSS
74  2020 Fusobacterium nucleatum Promotes the Development of Ulcerative Colitis by Inducing the Autophagic Cell Death of Intestinal Epithelial. 3-MA, CQ, IEC, LPS, UC
75  2020 Immune induction identified by TMT proteomics analysis in Fusobacterium nucleatum autoinducer-2 treated macrophages. AI-2, PAAD, QS, TNFSF9
76  2020 Inhibitory Effect of a KSL-W Peptide-Loaded Poloxamer 407-Based Microemulsions for Buccal Delivery on Fusobacterium nucleatum Biofilm. CLX, PLM, SAXS
77  2020 Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection. BMSCs
78  2020 Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis. CRC, IBD, iHMP, LDA
79  2020 Persistent Exposure to Fusobacterium nucleatum Triggers Chemokine/Cytokine Release and Inhibits the Proliferation and Osteogenic Differentiation Capabilities of Human Gingiva-Derived Mesenchymal Stem Cells. ALP, DEGs, GMSCs
80  2020 The Pathogenic Effects of Fusobacterium nucleatum on the Proliferation, Osteogenic Differentiation, and Transcriptome of Osteoblasts. DEGs, STEM
81  2020 The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management. CRC, miRNA, TLR2, TLR4
82  2019 Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum. CRC, CREBBP
83  2019 Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer. CI, EPIC, ORs
84  2019 Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer. BECN1, PCR
85  2019 Autoinducer-2 of Fusobacterium nucleatum promotes macrophage M1 polarization via TNFSF9/IL-1beta signaling. AI-2, CRC
86  2019 Effect of the aging of titanium and zirconia abutment surfaces on the viability, adhesion, and proliferation of cells and the adhesion of microorganisms. NOK-si, P. gingivalis, S. sanguinis, SEM, Ti
87  2019 Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity. CRC
88  2019 Fusobacterium nucleatum Facilitates Apoptosis, ROS Generation, and Inflammatory Cytokine Production by Activating AKT/MAPK and NF-kappaB Signaling Pathways in Human Gingival Fibroblasts. GFs, ROS
89  2019 Fusobacterium nucleatum stimulates monocyte adhesion to and transmigration through endothelial cells. ECs, HUVECs, IL
90  2019 Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1. CRC, NK
91  2019 Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients. CRC, HR
92  2019 Immunological Pathways Triggered by Porphyromonas gingivalis and Fusobacterium nucleatum: Therapeutic Possibilities? P. gingivalis
93  2019 Improved antibacterial effects of alkali-transformed saponin from quinoa husks against halitosis-related bacteria. ATS, C. perfringens, P. gingivalis, QS
94  2019 Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. ESCC, PET/CT, RECISTs, RFS, TRG
95  2019 Microbiome Dysbiosis and Predominant Bacterial Species as Human Cancer Biomarkers. CRC, G. adiacens, H. pylori, LC, P. gingivalis
96  2019 Novel nanotechnology and near-infrared photodynamic therapy to kill periodontitis-related biofilm pathogens and protect the periodontium. aPDT, CFU, NIR, P. gingivalis, S. sanguinis, UV
97  2019 Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers. CI, CRC, MSI, OR
98  2019 Relationship between Fusobacterium nucleatum, inflammatory mediators and microRNAs in colorectal carcinogenesis. CRA, CRC, miRNAs, MSI, qPCR
99  2019 Serum Levels of Interleukin-6 and Titers of Antibodies Against Porphyromonas gingivalis Could Be Potential Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma. ELISA, IL-6, OSCC, P. gingivalis
100  2019 Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy. CRC